To evaluate the necessary detailed mechanism on the molecular level and to support subjects with an increased genetic risk for developing breast cancer, further studies with higher numbers of participants are needed to implement HIT/HIRT program as a scientifically sound prospective prevention and/or treatment method to reduce the risk for the development of cancer in individuals with BRCA1 mutations. This evidence concerns the gene BRCA1 and cancer.